HMP Shunt Pathway Notes

Pentose Pathway / HMP Shunt Pathway

Case Presentation

  • A 32-year-old male of Mediterranean descent presents with jaundice, fatigue, and dark urine three days after taking trimethoprim-sulfamethoxazole for a urinary tract infection.

  • He denies significant past medical history but recalls his father experiencing a similar reaction after taking an antimalarial medication.

  • Examination findings:

    • Pale with icterus.

  • Laboratory workup:

    • Low hemoglobin.

    • Increased reticulocyte count.

    • Elevated indirect bilirubin.

    • Decreased haptoglobin.

    • Peripheral blood smear reveals bite cells.

    • G6PD enzyme assay confirms low enzyme activity.

Introduction

  • Instead of glucose going through the glycolytic pathway, it is shunted through the HMP shunt pathway.

  • Approximately 10% of glucose molecules per day enter this pathway.

  • The liver and RBCs metabolize about 30% of glucose via this pathway.

  • The major purpose is:

    • Generation of reduced NADPH

    • Production of pentose phosphates for nucleotide synthesis.

Overview of the Shunt Pathway

  • The HMP shunt pathway has two phases:

    • Oxidative phase

    • Non-oxidative phase

  • Oxidative Phase:

    • Glucose-6-phosphate is oxidized, generating 2 molecules of NADPH.

    • One molecule of pentose phosphate is produced.

    • One molecule of CO2CO_2 is liberated.

  • Non-Oxidative Phase:

    • Pentose phosphates are converted to intermediates of glycolysis.

Oxidative Phase

  • Reaction 1: Glucose-6-phosphate is oxidized by NADP+NADP^+-dependent Glucose-6-phosphate dehydrogenase (G6PD).

    • 6-phosphoglucono lactone is formed.

    • One molecule of NADPH is formed.

    • This is the rate-limiting step.

    • Regulation is affected by this enzyme.

Non-Oxidative Phase

  • Reactions:

    • Ribulose-5-phosphate is converted to Ribose-5-phosphate by Isomerase.

    • Ribulose-5-phosphate is converted to Xylulose-5-phosphate by Epimerase.

    • Transketolase converts Ribose 5-phosphate and Xylulose 5-phosphate into Glyceraldehyde 3-phosphate and Sedoheptulose 7-phosphate.

    • Transaldolase converts Xylulose 5-phosphate and Erythrose 4-phosphate into Fructose 6-phosphate and Glyceraldehyde 3-phosphate.

    • These products then feed into Glycolysis.

Regulation of HMP Shunt Pathway

  • The pathway is mainly regulated by the level of NADP+NADP^+.

  • The first reaction catalyzed by GPD is the rate-limiting step and is inhibited by NADPH.

  • The oxidative phase is controlled by the level of NADP+NADP^+.

  • The non-oxidative phase is controlled by the requirement of pentoses.

  • Insulin will induce GPD and therefore will increase the overall pathway.

  • When more NADPH is needed, the pathway proceeds to completion with the equivalent of one molecule of glucose being completely oxidized to CO2CO_2.

Summary of Shunt Pathway

  • Suppose 6 molecules of glucose (6 × 6 = 36 carbons) enter this pathway.

  • The first carbon atoms of all 6 glucose molecules are removed as 6 molecules of CO2CO_2 (equivalent to complete oxidation of 1 molecule of glucose).

  • In this process, 12 NADPH are generated.

  • The remaining 6 molecules of 5-carbon pentoses (6 × 5 = 30C) are further metabolized.

  • Simplified Stoichiometry:

    • 6 x glucose-6-P + 12 NADP+NADP^+ + 6 H<em>2OH<em>2O --> 5 x glucose-6-P + 6 CO</em>2CO</em>2 + 12 NADPH + 12 H+H^+ + Pi

    • Net: 1 glucose-6-phosphate is completely oxidized to 6 CO2CO_2

Significance of HMP Shunt Pathway

  • Metabolic Importance:

    1. To produce NADPH and pentose phosphates

      • NADPH is required for:

        • Reductive biosynthesis (fatty acids, cholesterol, steroid hormones).

        • Free radical scavenging.

        • Maintaining RBC membrane integrity by keeping GSH in the reduced state.

        • Prevention of methemoglobin formation.

        • Detoxification by hydroxylation.

        • Maintaining the transparency of the lens.

        • Bactericidal activity of macrophages.

      • Ribose-5-phosphate is required for nucleic acid synthesis.

  • Clinical Importance:

    1. Glucose-6-phosphate dehydrogenase deficiency

    2. Drug-induced hemolytic anemia

    3. Met-hemoglobinemia

    4. Thiamine deficiency leads to reduced transketolase activity

Pathway Location

  • Pathway operates in the following organs:

    • Liver

    • Adipose tissue

    • Adrenal cortex

    • Mammary glands

    • Testes and ovaries

    • RBCs

    • Lens of the eye

  • The oxidative phase of the pathway is seen in organs where NADPH generation is required for lipid or steroid synthesis.

  • The non-oxidative phase is present in all tissues, so synthesis of ribose is possible in all tissues of the body.

Erythrocyte Membrane Integrity

  • NADPH is required by the RBC to keep glutathione in the reduced state.

  • Reduced glutathione detoxifies peroxides and free radicals formed within the RBC.

  • NADPH, glutathione, and glutathione reductase together preserve the integrity of the RBC membrane.

G6PD Deficiency

  • The enzyme glucose-6-phosphate dehydrogenase (G6PD) may be deficient in some persons.

  • It is the most common enzyme deficiency seen in clinical practice.

  • The defect is transmitted as an X-linked recessive trait.

Role of G-6-PD in RBC membrane stability

  • G6PD enzyme helps generate NADPH which is needed for reduced glutathione

  • Reduced glutathione maintains the RBCs membrane.

G6PD Deficiency and Drug-Induced Hemolytic Anemia

  • G6PD deficiency leads to drug-induced hemolytic anemia.

  • The deficiency is manifested only when exposed to certain drugs or toxins (e.g., antimalarial drugs like primaquine).

  • Primaquine stimulates peroxide formation inside RBCs.

  • In GPD deficient cells, the level of NADPH is low; hence, further production of peroxides will lead to cell lysis.

  • Ingestion of toxic glycosides present in fava beans may have a similar effect (Favism).

  • Sulfa drugs and furadantin may also precipitate hemolysis, leading to jaundice and severe anemia.

Availability of Ribose

  • Ribose and deoxyribose are required for DNA and RNA synthesis.

  • Ribose is also necessary for nucleotide co-enzymes.

  • Reversal of the non-oxidative phase is present in all tissues, by which ribose could be made available.

ATP Production

  • ATP is neither utilized nor produced by the HMP shunt pathway.

  • Cells do not use the shunt pathway for energy production.

Detoxification of Drugs

  • Most drugs and other foreign substances are detoxified by liver microsomal P450 enzymes with the help of NADPH.

Lens of Eye

  • Maximum concentration of NADPH is seen in the lens of the eye.

  • NADPH is required for preserving the transparency of the lens.

Prevention of Met-Hemoglobinemia

  • NADPH is also required to keep the iron of hemoglobin in the reduced (ferrous) state and to prevent the accumulation of met-hemoglobin.

  • Met-hemoglobin cannot carry oxygen.

Macrophage Bactericidal Activity

  • NADPH is required for the production of reactive oxygen species (ROS) (superoxide anion radical) by macrophages to kill bacteria.

Free Radical Scavenging

  • Free radicals (superoxide, hydrogen peroxide) are continuously produced in all cells.

  • These can destroy DNA, proteins, fatty acids, and other biomolecules, leading to cell destruction.

  • The free radicals are inactivated by enzyme systems containing superoxide dismutase (SOD), peroxidase (POD), and glutathione reductase (GR).

  • Reduced GR is regenerated with the help of NADPH.

  • Reactions:

    • O<em>2O<em>2^- + O</em>2O</em>2^- + 2H+H^+ SOD\underrightarrow{SOD} H<em>2O</em>2H<em>2O</em>2 + O2O_2

    • H<em>2O</em>2H<em>2O</em>2 POD\underrightarrow{POD} 2H2O2H_2O

    • 2GSH (reduced) GR\underrightarrow{GR} GS--SG (oxidized)

Key Investigations for G6PD Deficiency

Test

Findings in G6PD Deficiency

Clinical Significance

Complete Blood Count (CBC)

Low hemoglobin (Hb), increased reticulocyte count

Indicates hemolytic anemia

Peripheral Blood Smear

Bite cells, Heinz bodies (with special staining)

Suggests oxidative damage to RBCs

Reticulocyte Count

Elevated (>2.5%)

Bone marrow response to anemia

Serum Bilirubin

Increased indirect (unconjugated) bilirubin

Due to hemolysis

Lactate Dehydrogenase (LDH)

Elevated

Marker of RBC destruction

Haptoglobin

Decreased

Binds free hemoglobin, decreased in hemolysis

Urinalysis

Hemoglobinuria, no RBCs

Suggests intravascular hemolysis

G6PD Enzyme Assay

Decreased enzyme activity

Confirms G6PD deficiency; performed after hemolytic crisis resolves

Coombs Test

Negative

Rules out immune-mediated hemolysis